Biodistribution of titanium dioxide from biologic compartments

Area of Science:

• Biomaterials Science
• Nanotoxicology
• Implantology

Background:

• Titanium dioxide (TiO2) is used in clinical implants.
• Chronic exposure to TiO2 in the peri-implant environment raises concerns about material degradation and biological effects.
• Understanding TiO2 biodistribution is crucial for assessing implant safety.

Purpose of the Study:

• To evaluate and compare the chronic effects and biodistribution of TiO2 administered via subcutaneous and intraperitoneal routes.
• To investigate the potential for systemic migration of TiO2 from a localized injection site.
• To model the biological compartment of implants for metal ion release studies.

Main Methods:

• Subcutaneous and intraperitoneal administration of TiO2 in rats.
• Histological analysis to identify TiO2 deposits in skin, liver, and lungs.
• Energy-dispersive X-ray (EDX) spectroscopy for elemental characterization.
• Immunohistochemical staining for CD68 to identify macrophage-like cells.

Main Results:

• Histological evidence of TiO2 deposits was observed in the skin, liver, and lungs following both administration routes.
• CD68 staining confirmed the presence of macrophage-like cells in affected tissues.
• Despite compartmentalization in subcutaneous injection sites, systemic migration of TiO2 was confirmed.

Conclusions:

• Systemic migration of TiO2 occurs irrespective of the administration route (subcutaneous or intraperitoneal).
• TiO2 nanoparticles can disseminate from localized depots to distant organs.
• These findings highlight potential risks associated with chronic exposure to TiO2 in biomedical applications.